Compliance and Quality

Compliance and Quality

At MOCA Health, ensuring the safety, efficacy, and quality of our medical cannabis products is our top priority. As a fully licensed importer and wholesaler of medical cannabis, we are committed to maintaining the highest standards in product quality and compliance with regulatory frameworks. We take a proactive approach in adhering to the stringent guidelines set by the Therapeutic Goods Administration (TGA) and follow internationally recognized quality control processes to guarantee that our products meet the highest safety and effectiveness standards.

MOCA’s Adherence to TGA Regulations

MOCA Health operates in full compliance with the Therapeutic Goods Administration (TGA), Australia’s regulatory authority overseeing the safety, quality, and efficacy of medicines. The TGA ensures that all medical cannabis products, including oils, capsules, and flowers, meet the necessary standards for patient safety.

Our commitment to TGA compliance involves:

• Registration and Licensing: MOCA Health is a fully licensed importer and wholesaler, authorized by the TGA to supply medical cannabis products in Australia. This ensures that we operate within the legal frameworks that regulate the importation and distribution of therapeutic goods.

• Strict Adherence to the Special Access Scheme (SAS) and Authorised Prescriber (AP) Pathways: Our products are available through the Special Access Scheme (SAS) and Authorised Prescriber (AP) pathways, both of which are regulated by the TGA. We ensure that all prescriptions are processed according to these approved channels, ensuring the right care for patients.

• Ongoing Regulatory Monitoring: MOCA Health regularly reviews and updates its operations to align with any new regulatory changes issued by the TGA. This helps ensure that our business remains compliant with evolving laws and that our products meet or exceed the regulatory requirements.

By maintaining full TGA compliance, MOCA Health ensures that patients receive safe, high-quality medical cannabis products. Our adherence to these guidelines provides peace of mind to both practitioners and patients that they are using products that meet Australian standards.

Strict Quality Control Measures

At MOCA Health, quality control is integral to every step of our product lifecycle. From sourcing raw materials to the final product packaging, we implement strict measures to ensure that our cannabis products are of the highest quality. Our quality assurance processes include:

• Good Manufacturing Practice (GMP): We work exclusively with suppliers and manufacturers who adhere to Good Manufacturing Practice (GMP). This internationally recognised standard ensures that our cannabis products are consistently produced and controlled according to strict quality standards.

• Traceability and Transparency: We maintain full traceability for every product, ensuring that each batch is accounted for from cultivation through to distribution. This level of transparency allows us to verify that the products meet the specifications set for their quality and safety.

• Quality Control Testing: Each batch of cannabis products is subject to rigorous quality control testing to verify that it meets the specified potency, purity, and safety standards. This testing covers factors such as cannabinoid content, absence of contaminants (e.g., pesticides, heavy metals), and overall product consistency.

Third-Party Testing and Certification Processes

To provide further assurance of our product quality and to maintain transparency, MOCA Health utilizes third-party testing and certification processes. These independent tests ensure that our cannabis products meet or exceed industry standards for safety, potency, and purity.

• Independent Laboratories: MOCA Health works with accredited third-party laboratories that specialize in cannabis testing. These labs test our products for cannabinoid profile, ensuring that the THC, CBD, and other cannabinoids are accurately represented on the product label. They also test for potential contaminants such as heavy metals, pesticides, residual solvents, and mold, which could affect the safety of the product.

• Certification of Analysis (COA): Each batch of MOCA Health products undergoes third-party testing and is accompanied by a Certificate of Analysis (COA). This document provides the results of the tests conducted, detailing the cannabinoid content and confirming that the product is free from harmful contaminants. We make these COAs available to healthcare professionals and patients to ensure full transparency.

• Rigorous Testing Protocols: The third-party testing process follows strict protocols, using state-of-the-art technology to ensure accuracy. This process provides an additional layer of assurance for our patients and healthcare providers, demonstrating our commitment to the highest quality standards.

• Conclusion

MOCA Health is committed to delivering medical cannabis products that meet the highest standards of quality and safety. Our adherence to TGA regulations, combined with strict quality control measures and third-party testing, ensures that our products are both safe and effective for patients.

By prioritising compliance and quality at every stage of our operations, we provide our patients, practitioners, and partners with confidence in the products we supply. Whether you're a healthcare provider seeking reliable cannabis-based therapies for your patients or a patient looking for high-quality, regulated treatment, MOCA Health is dedicated to supporting your journey with the best possible products and services.

For more information on our quality standards and regulatory compliance, please contact us or visit our Compliance and Quality page.